Cargando…
Circulating cytokeratin-positive cells and tumor budding in colorectal cancer
AIM: To investigate whether circulating cytokeratin-positive (CK(+)) cells in the mesenteric blood of resected colorectal specimens are prognostic and correlate with tumor budding. METHODS: Fifty-six colorectal specimens were collected between 9/2007 and 7/2008. Blood from the mesenteric vein was dr...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5143437/ https://www.ncbi.nlm.nih.gov/pubmed/28008384 http://dx.doi.org/10.5306/wjco.v7.i6.433 |
_version_ | 1782472940224249856 |
---|---|
author | Märkl, Bruno Wilhelms, Narjes Anthuber, Matthias Schenkirsch, Gerhard Schlimok, Günter Oruzio, Daniel |
author_facet | Märkl, Bruno Wilhelms, Narjes Anthuber, Matthias Schenkirsch, Gerhard Schlimok, Günter Oruzio, Daniel |
author_sort | Märkl, Bruno |
collection | PubMed |
description | AIM: To investigate whether circulating cytokeratin-positive (CK(+)) cells in the mesenteric blood of resected colorectal specimens are prognostic and correlate with tumor budding. METHODS: Fifty-six colorectal specimens were collected between 9/2007 and 7/2008. Blood from the mesenteric vein was drawn immediately after receiving the fresh and unfixed specimens in the pathology department. After separation of the mononuclear cells by Ficoll-Hypaque density-gradient centrifugation, cytological smears were immunocytochemically stained for CK18. Tumor budding was evaluated on slides stained for pan-cytokeratin. The identification of ≥ 30 buds/1.3 mm(2) was defined as high grade budding. RESULTS: CK(+) cells and clusters were identified in 29 (48%) and 14 (25%) of the samples, respectively. Two cells were identified in one of three non-malignant cases. Clusters were found exclusively in malignant cases. The occurrence of CK(+) cells or clusters was not associated with any of the evaluated clinicopathological factors, including surgical technique and tumor budding. Moreover, the occurrence of CK(+) cells or clusters had no influence on the cancer-specific survival [75 mo (CI: 61; 88) vs 83 mo (CI: 72; 95) and 80 mo (CI: 63; 98) vs 79 mo (CI: 69; 89), respectively]. CONCLUSION: CK(+) cells and showed neither prognostic significance nor an association with tumor budding. It is very likely that CK18-staining is not specific enough to identify the relevant cells. |
format | Online Article Text |
id | pubmed-5143437 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-51434372016-12-23 Circulating cytokeratin-positive cells and tumor budding in colorectal cancer Märkl, Bruno Wilhelms, Narjes Anthuber, Matthias Schenkirsch, Gerhard Schlimok, Günter Oruzio, Daniel World J Clin Oncol Retrospective Study AIM: To investigate whether circulating cytokeratin-positive (CK(+)) cells in the mesenteric blood of resected colorectal specimens are prognostic and correlate with tumor budding. METHODS: Fifty-six colorectal specimens were collected between 9/2007 and 7/2008. Blood from the mesenteric vein was drawn immediately after receiving the fresh and unfixed specimens in the pathology department. After separation of the mononuclear cells by Ficoll-Hypaque density-gradient centrifugation, cytological smears were immunocytochemically stained for CK18. Tumor budding was evaluated on slides stained for pan-cytokeratin. The identification of ≥ 30 buds/1.3 mm(2) was defined as high grade budding. RESULTS: CK(+) cells and clusters were identified in 29 (48%) and 14 (25%) of the samples, respectively. Two cells were identified in one of three non-malignant cases. Clusters were found exclusively in malignant cases. The occurrence of CK(+) cells or clusters was not associated with any of the evaluated clinicopathological factors, including surgical technique and tumor budding. Moreover, the occurrence of CK(+) cells or clusters had no influence on the cancer-specific survival [75 mo (CI: 61; 88) vs 83 mo (CI: 72; 95) and 80 mo (CI: 63; 98) vs 79 mo (CI: 69; 89), respectively]. CONCLUSION: CK(+) cells and showed neither prognostic significance nor an association with tumor budding. It is very likely that CK18-staining is not specific enough to identify the relevant cells. Baishideng Publishing Group Inc 2016-12-10 2016-12-10 /pmc/articles/PMC5143437/ /pubmed/28008384 http://dx.doi.org/10.5306/wjco.v7.i6.433 Text en ©The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. |
spellingShingle | Retrospective Study Märkl, Bruno Wilhelms, Narjes Anthuber, Matthias Schenkirsch, Gerhard Schlimok, Günter Oruzio, Daniel Circulating cytokeratin-positive cells and tumor budding in colorectal cancer |
title | Circulating cytokeratin-positive cells and tumor budding in colorectal cancer |
title_full | Circulating cytokeratin-positive cells and tumor budding in colorectal cancer |
title_fullStr | Circulating cytokeratin-positive cells and tumor budding in colorectal cancer |
title_full_unstemmed | Circulating cytokeratin-positive cells and tumor budding in colorectal cancer |
title_short | Circulating cytokeratin-positive cells and tumor budding in colorectal cancer |
title_sort | circulating cytokeratin-positive cells and tumor budding in colorectal cancer |
topic | Retrospective Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5143437/ https://www.ncbi.nlm.nih.gov/pubmed/28008384 http://dx.doi.org/10.5306/wjco.v7.i6.433 |
work_keys_str_mv | AT marklbruno circulatingcytokeratinpositivecellsandtumorbuddingincolorectalcancer AT wilhelmsnarjes circulatingcytokeratinpositivecellsandtumorbuddingincolorectalcancer AT anthubermatthias circulatingcytokeratinpositivecellsandtumorbuddingincolorectalcancer AT schenkirschgerhard circulatingcytokeratinpositivecellsandtumorbuddingincolorectalcancer AT schlimokgunter circulatingcytokeratinpositivecellsandtumorbuddingincolorectalcancer AT oruziodaniel circulatingcytokeratinpositivecellsandtumorbuddingincolorectalcancer |